Financials Dezhan Healthcare Company Limited

Equities

000813

CNE000000VV8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 23:00:00 16/05/2024 BST 5-day change 1st Jan Change
2.69 CNY +0.37% Intraday chart for Dezhan Healthcare Company Limited -9.12% -17.74%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 20,435 13,950 9,825 9,027 8,229 7,046
Enterprise Value (EV) 1 18,538 10,377 6,311 6,547 5,239 4,257
P/E ratio 22.1 x 41.4 x 34.6 x -158 x -175 x 85.6 x
Yield - - 4.74% - - -
Capitalization / Revenue 6.21 x 7.86 x 10.2 x 12.3 x 14.4 x 14.1 x
EV / Revenue 5.63 x 5.85 x 6.55 x 8.91 x 9.18 x 8.55 x
EV / EBITDA 17.2 x 29.1 x 20.9 x 51.4 x -81.5 x 173 x
EV / FCF 251 x 5.97 x 16.9 x 177 x 38.2 x -33.2 x
FCF Yield 0.4% 16.8% 5.93% 0.57% 2.62% -3.01%
Price to Book 3.86 x 2.49 x 1.67 x 0.7 x 1.55 x 1.35 x
Nbr of stocks (in thousands) 2,226,031 2,217,870 2,217,870 2,217,870 2,218,178 2,154,623
Reference price 2 9.180 6.290 4.430 4.070 3.710 3.270
Announcement Date 26/04/19 28/04/20 28/04/21 26/04/22 27/04/23 11/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 3,291 1,775 962.9 734.5 570.9 498.1
EBITDA 1 1,075 357.2 302.1 127.4 -64.27 24.61
EBIT 1 1,030 305.2 234 49.77 -153.1 -55.69
Operating Margin 31.31% 17.2% 24.3% 6.78% -26.82% -11.18%
Earnings before Tax (EBT) 1 1,053 387.8 349.3 -37.11 -121.1 81.84
Net income 1 930.5 336.9 284.5 -57.58 -46.91 83.31
Net margin 28.28% 18.98% 29.55% -7.84% -8.22% 16.73%
EPS 2 0.4162 0.1519 0.1282 -0.0257 -0.0212 0.0382
Free Cash Flow 1 73.84 1,739 373.9 37.09 137.2 -128.2
FCF margin 2.24% 97.99% 38.83% 5.05% 24.03% -25.74%
FCF Conversion (EBITDA) 6.87% 486.99% 123.76% 29.11% - -
FCF Conversion (Net income) 7.94% 516.23% 131.41% - - -
Dividend per Share - - 0.2100 - - -
Announcement Date 26/04/19 28/04/20 28/04/21 26/04/22 27/04/23 11/04/24
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1
Net sales -
EBITDA -
EBIT -
Operating Margin -
Earnings before Tax (EBT) -
Net income 1 30.45
Net margin -
EPS 2 0.0136
Dividend per Share -
Announcement Date 29/04/22
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 1,897 3,574 3,514 2,480 2,990 2,789
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 73.8 1,739 374 37.1 137 -128
ROE (net income / shareholders' equity) 18.9% 6.16% 4.73% -1.68% -2.85% 1.03%
ROA (Net income/ Total Assets) 11.6% 3.22% 2.37% 0.51% -1.67% -0.63%
Assets 1 7,992 10,464 11,994 -11,273 2,807 -13,233
Book Value Per Share 2 2.380 2.530 2.650 5.830 2.390 2.420
Cash Flow per Share 2 0.6500 0.6700 1.090 1.600 1.170 1.290
Capex 1 68.6 65.1 110 127 67.6 160
Capex / Sales 2.08% 3.67% 11.45% 17.28% 11.83% 32.07%
Announcement Date 26/04/19 28/04/20 28/04/21 26/04/22 27/04/23 11/04/24
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 000813 Stock
  4. Financials Dezhan Healthcare Company Limited